Antiviral drugs attack the viral enzymes or the steps a host cell does not perform. Nucleoside analogues are chain terminators: aciclovir is phosphorylated only by the herpesvirus thymidine kinase and then blocks the viral DNA polymerase, so it acts only in infected cells; AZT, tenofovir and lamivudine stop reverse transcriptase; remdesivir and molnupiravir act on the coronavirus polymerase, the second by mutagenesis. Protease inhibitors block the cleavage of viral polyproteins (HIV, hepatitis C, SARS-CoV-2’s nirmatrelvir). Integrase inhibitors stop HIV’s provirus forming; neuraminidase inhibitors stop influenza virions detaching from the cell they bud from; entry inhibitors block a receptor. The hepatitis C virus is now cured in twelve weeks by combinations of direct-acting drugs, the first chronic viral infection ever cured by chemotherapy. Vaccines present the virus’s antigens without its disease: a live attenuated virus (measles, polio by mouth, yellow fever), an inactivated virus (polio by injection, influenza), a subunit (the hepatitis B surface antigen made in yeast, the papillomavirus capsid protein), a harmless viral vector carrying a gene of the target, or, since 2020, messenger RNA encoding the antigen, delivered in lipid nanoparticles, which the recipient’s own cells translate. The immunology of why they work, and of how many must be vaccinated to protect the rest, is the matter of Chapter 16.
Examples
Example 13.6 (HIV before and after the equations)
Until 1995 the years of clinical latency of HIV infection — a stable viral load of – copies per millilitre and a slow fall of T cells — were read as a quiescent virus. Ho, Perelson and colleagues gave patients a protease inhibitor and fitted the decline of the viral load to the theorem: the fast phase gave (a virion half-life of about six hours), the slow phase (an infected cell lives about a day and a half). A steady load of per millilitre in of body fluid, cleared at , therefore requires the production of about virions a day, every day, for years: the “latent” period is a furious steady state of infection and death, with the T cell pool replaced daily until it fails. The mutation arithmetic of the next section then follows at once, and with it the reason single drugs failed and three did not.
Example 13.9 (Why HIV needed three drugs)
HIV’s reverse transcriptase errs about once in nucleotides, so each genome copied carries about mutations, and new genomes a day carry mutations among them: every one of the possible single point mutations arises many times every day, before any drug is given. A drug that a single mutation defeats — as one mutation defeats most reverse-transcriptase and protease inhibitors — is therefore defeated within weeks, which is what happened to AZT in 1987. Two independent mutations arise together at per genome, about once a day; three at , once in a thousand days — and a patient on three drugs whose load has fallen a thousandfold produces genomes a day, so the triple mutant never appears. That, and the theorem’s demonstration that the virus was replicating at full speed, made combination therapy from 1996 the treatment that turned AIDS into a chronic condition.